Literature DB >> 12002231

Nonrandom selection and the attributable cost of surgical-site infections.

Christopher S Hollenbeak1, Denise Murphy, William C Dunagan, Victoria J Fraser.   

Abstract

OBJECTIVE: To study the extent to which selection bias poses problems for estimating the attributable cost of deep chest surgical-site infection (SSI) following coronary artery bypass graft (CABG) surgery.
DESIGN: Reanalysis of a prospective case-control study.
SETTING: A large, Midwestern community medical center. PATIENTS: Cases were all patients who had an SSI (N = 41) following CABG and CABG and valve surgery between April 1996 and March 1998. Controls were every tenth uninfected patient (N = 160).
METHODS: Estimates of the attributable cost of deep chest SSI were computed using unmatched comparison, matched comparison, linear regression, and Heckman's two-stage approach.
RESULTS: The attributable cost of deep chest SSI was estimated to be $20,012 by unmatched comparison, $19,579 by matched comparison, $20,103 by linear regression, and $14,211 by Heckman's two-stage method. Controlling for selection bias substantially reduced the cost estimate, but the coefficient capturing selection bias was not statistically significant.
CONCLUSIONS: Deep chest SSI significantly increases the cost of care for patients who undergo CABG surgery. Unmatched comparison, matched comparison, and linear regression estimated the attributable cost to be approximately $20,000. Although controlling for selection bias with Heckman's two-stage method resulted in a substantially smaller estimate, the coefficient for selection bias was not statistically significant, suggesting that the estimates derived from the other models should be acceptable. However, the magnitude of the difference between the models shows that the effect of selection bias can be substantial. Some exploration for selection bias is recommended when estimating the attributable cost of SSIs.

Entities:  

Mesh:

Year:  2002        PMID: 12002231     DOI: 10.1086/502032

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  17 in total

1.  Incidence, microbiological findings, and clinical presentation of sternal wound infections after cardiac surgery with and without local gentamicin prophylaxis.

Authors:  O Friberg; R Svedjeholm; J Källman; B Söderquist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

Review 2.  Costs of hospital-acquired infection and transferability of the estimates: a systematic review.

Authors:  H Fukuda; J Lee; Y Imanaka
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

3.  Wound morbidity in mini-invasive thyroidectomy.

Authors:  Gianlorenzo Dionigi; Luigi Boni; Francesca Rovera; Stefano Rausei; Renzo Dionigi
Journal:  Surg Endosc       Date:  2010-06-05       Impact factor: 4.584

4.  [Responsibility of surgeons for surgical site infections].

Authors:  P Gastmeier; C Brandt; D Sohr; H Rüden
Journal:  Chirurg       Date:  2006-06       Impact factor: 0.955

5.  Neonatal nosocomial infections in Bahrami Children Hospital.

Authors:  Payman Salamati; Ali Akbar Rahbarimanesh; Masood Yunesian; Mohsen Naseri
Journal:  Indian J Pediatr       Date:  2006-03       Impact factor: 1.967

6.  Update on the Epidemiology and Prevention of Surgical Site Infections.

Authors:  Tae Chong; Robert Sawyer
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.725

Review 7.  Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs.

Authors:  Günter Kampf; Axel Kramer
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Improving surveillance system and surgical site infection rates through a network: A pilot study from Thailand.

Authors:  Nongyao Kasatpibal; Mette Nørgaard; Silom Jamulitrat
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

9.  Variations in identification of healthcare-associated infections.

Authors:  Sara C Keller; Darren R Linkin; Neil O Fishman; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2013-05-21       Impact factor: 3.254

10.  Ceftobiprole medocaril is an effective treatment against methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a rat model.

Authors:  Y Barnea; S Navon-Venezia; B Kuzmenko; N Artzi; Y Carmeli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-14       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.